kff 2025 employer health benefits survey glp-1 coverage Among the largest employers (with at least 5,000 workers), 43% now cover GLP -1 weight-loss drugs, up from 28% last year. A majority (59%) of those same employers say their cost for the GLP-1 Drugs: 2025 Pulse Survey

This discrepancy between the current post-marketing findings and prior clinical trial evidence highlights the significance of ongoing pharmacovigilance and real-world evidence studies in identifying rare but potentially serious adverse effects that may not be captured in pre-approval clinical trials

G.KarlssonK

Glentham life sciences very high quality products company Excellent range of chemicals and Excellent range of chemicals and buffers combined with great service and pricing

adults had heard of GLP-1 drugs, up from 70 percent in a previous NORC survey conducted in May 2024

Bo ph thch thc sc khe ton cu ngy cng gia tng 2

This is a transformational moment in science, but were going to see widening disparities, because the people who have access to these medications are not the same people who have the highest risk of conditions like obesity and diabetes, he said